Product Overview
Recombinant SARS Associated Coronavirus, Nucleocapsid, contains the Nucleocapsid protein immunodominant region and a GST fusion partner. Immunoreactive with SARS positive sera. It may appear as multiple bands on SDS-PAGE (intact protein at 31.7kDa, GST fu
Molecular Weight
31.7 kDa
Alternative Names
SARS Nucleocapsid; SARS; SARS NP; SARS Nucleoprotein; SARS N Protein
Purity
> 95% pure (10% PAGE, coomassie staining). GS-4B Sepharose-Affinity Purification.
Concentration
1 mg/ml (Bradford method)
Buffer
50mM Tris-HCl, pH 8.0, 60mM Sodium Chloride containing 50% glycerol
Storage
Upon receipt, store at -20°C
Introduction
A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive stranded RNA approximately 27 to 31kb in length.
Keywords
SARS Nucleocapsid; SARS; SARS NP; SARS Nucleoprotein; SARS N Protein
Citations
Publication ()
Have you cited DAG522 in a publication?
Let us know and earn a reward for your research.